Pharmacists in Waupun, Wisconsin


13 Pharmacists found in Waupun
female pharmacist

Alannah L Wallsten, PHARMD


Pharmacist
999 E Main St, Waupun, WI 53963
920-324-4696    

female pharmacist

Carole Marie Cronin, R.PH.


Pharmacist
910 W Main St, Waupun, WI 53963
920-324-3010     920-324-3875

male pharmacist

Dale A Wszalek


Pharmacist
999 E Main St, Waupun, WI 53963
920-324-4696    



male pharmacist

Dr. Dario Savic, PHARMD


Pharmacist
999 E Main St, Waupun, WI 53963
920-324-4696    

male pharmacist

Dr. Ethan A. Carruthers, PHARMD


Pharmacist
999 E Main St, Waupun, WI 53963
920-324-4696     920-324-4910

male pharmacist

James Alfred Vanderwerff, R.PH


Pharmacist
904 W Main St, Waupun, WI 53963
920-324-5355     920-324-3875

female pharmacist

Jane Marie Kelsey, RPH


Pharmacist
904 W Main St, Waupun, WI 53963
920-324-3010     920-324-3875

male pharmacist

Dr. John Francis Winters, PHARM D.


Pharmacist
904 W Main St, Waupun, WI 53963
920-324-3010     920-324-3875

female pharmacist

Mrs. Kristy Love Buteyn, PHARMD


Pharmacist
904 W Main St, Waupun, WI 53963
920-324-3010    

male pharmacist

Larry Edwards, R.PH.


Pharmacist
208 S West St, Waupun, WI 53963
920-324-1600    

male pharmacist

Robert Steven Schreiber, RPH


Pharmacist
208 S West St, Waupun, WI 53963
920-324-1600    

female pharmacist

Samantha Lynn Lenzendorf


Pharmacist
999 E Main St, Waupun, WI 53963
920-324-4696     920-324-4910

female pharmacist

Dr. Sarah Embjorg Nelson, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
208 S West St, Waupun, WI 53963
920-324-1600    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.